The outcomes reflected that SBF2-AS1 expression was not related with age, histological type, histological grade and TNM stage (all P > 0.05), while was correlated with LNM, tumor size and clinical stage of BC patients (all P < 0.05). This evidence concerns the gene SBF2 and breast cancer.